Clinical Trial Resource Center

Therapeutic Areas

Cardiology/Vascular Diseases
Dental and Oral Health
Dermatology
Endocrinology
Gastroenterology
Hematology
Immunology
Infections and Infectious Diseases
Musculoskeletal
Nephrology
Neurology
Nutrition and Weight Loss
Obstetrics/Gynecology (Women’s Health)
Oncology
Ophthalmology
Otolaryngology (Ear, Nose, Throat)
Pediatrics/Neonatology
Pharmacology/Toxicology
Psychiatry/Psychology
Pulmonary/Respiratory Diseases
Rheumatology
Trauma (Emergency, Injury, Surgery)
Urology

Center Overview

The Mexican Institute of Clinical Research is an institution fully dedicated to conduct clinical research in Mexico covering most therapeutic areas, with an affiliation with major medical centers from the public and private sector. We are served by central IRB that independently meet every other week to review and approve submitted protocols. IMIC also provide the service of protocol submission before the local Ministry of Health in order to conduct the trial in Mexico under the local legislations.

IMIC clinical research activities are performed under the strict guidelines of the GCP-ICH, local regulations and sponsor directives. We have created an infrastructure in order to observe these guidelines by establishing dedicated supporting groups that will assist the study teams and the protocol to be in compliance. The dedicated groups are Telemarketing department that assist the investigators design subject recruitment strategies; Project Management to assist in the planning of the study logistics; Quality Assurance that under the quality control process assist the research teams be in compliance. In addition IMIC has a pharmacy and laboratory that helps maintain the control of the study drug inventories and perform the study specimen collection procedures respectively.

Clinical Research Experience

IMIC has been in operations since March of 2000 conducting clinical research from Phase I - IV. IMIC has full time trained study coordinators with background in medical science form physicians, biologist, psychologists, and nutritionist. All study personnel are trained under the regulatory discipline of the ICH, GCP and local regulations.

Our experience is based on the following areas:

• Cardiology
  • Hypertension
  • Cardiovascular
  • Essential Hypertension
  • Moderate Hypertension
  • Congestive Heart Failure (NYHU Class11/111)
• Dental
  • Pain Study
• Dermatology
  • Dry Skin
  • Atopic Dermatitis
  • Atopic Dermatitis (Pediatric)
  • Psoriasis
  • Onycomycosis
  • Neurofibromatosis
  • Atopic Dermatitis (Pediatric)
• Endocrinology
  • Diabetes
  • Diabetes (Naive)
  • Diabetes (Pediatric)
  • Diabetes (Inhaled Insulin)
  • Diabetes (Type 2 - Inhaled Insulin)
  • Diabetes (Type 1 & 2 - Inhaled Insulin)
  • Diabetic (Neuropathy)
  • Diabetes (Type 2 - tx with Metformin)
• ENT (Ear, Nose & Throat)
  • Allergic Rhinitis
• Gastroenterology
  • Clostridium Dificile
  • Irritable Bowel Syndrome
  • Bariatric Surgical Device
  • Ulcerative Colitis
• Hematology
  • Iron Deficiency Anemia (Secondary to heavy Uterine Bleeding)
  • Iron Deficiency Anemia (In non-dialysis dependent pediatric patients)
• Immunology-Infectious Diseases
  • HIV/AIDS (Pediatric)
  • Vaccine
  • Vaccine (Rotavirus)
• Nephrology-Urology
  • Prostatic Hyperplasia
  • Urinary Retention
  • Parkinson Disease
  • Peritoneal Dialysis
• Neurology-CNS
  • Panic Disorder
  • Depression
  • Anxiety
  • Major Depression
• Nutrition
  • Obesity
• Obstetrics-Gynecology
  • Papiloma Virus
  • Bacterial Vaginosis
  • BV-VV Candidacies Infection
  • Post Partum Anemia
• Oncology
  • Prostate Cancer
  • Lung Cancer
  • Pancreatic Cancer
  • Breast Cancer
• Ophthalmology
  • Glaucoma (Pediatric)
  • Glaucoma
  • Conjunctivitis
  • Keratoplasty
  • Macular Degeneration
• Pulmonary
  • Asthma
  • Asthma (Pediatric)
• Rheumatology
  • Osteoporosis
  • Osteoarthritis
  • Rheumatoid Arthritis

Facility Description

IMIC is located in Mexico City near the downtown area with easy access to patients and visitors via subway or any other kind of transportation. Our facility consists of 13,000 SF of space with 10 equipped medical offices, pharmacy, laboratory, central file, and monitoring office that are integrated to facilitate the conduction of the trial. IMIC has also integrated a computer and telephone system that facilitate the communication with our clients and the industry in cases such as IVRS for patient randomization and the use of electronic CRF.

Investigator Experience

IMIC has among the investigators’ experience an investigator network that allows us to select the investigator in any of the therapeutic areas required for the conduction of the study either in-house or with any of the affiliate medical institutions. The network includes trained investigators within the private and or public institutions where they are currently practice and where the study is conducted.

Staff Expertise

Adolfo Dorenbaum, BSBA - Chief Executive Officer

Mr. Dorenbaum obtained his BSBA from Boston University, Boston, MA. He has spent many years as a consultant setting upnew business in Mexico City; with extensive experience in financial management. He has participated in the publicadministration privatization process, instrumental for the odernization of Mexican economy. At present, he is responsible forIMIC’s contracts and financial-related activities.

Gina Gorodezky, MD - Medical Director

Dr. Gorodezky obtained her Medical Doctor degree from the Universidad NacionalAutonoma de Mexico. Was trained at M.D.Anderson Research Cancer Center as a Hemato/oncologist. She has worked at the Cancer Institute in Mexico City and at theMexican Cardiology Institute. She has participated in multiple clinical research studies in Mexico, USA., United Kingdom andEuropean Union.

Marc D. Russo, MCSE - Business Development & Marketing / CTO

Mr. Russo is an experienced entrepreneur, with a background of business set-up, organization, and coordination in diversecommercial ambiences. He entered the Clinical Research environment through one of his areas of expertise, computerconsulting, and rapidly joined IMIC’s marketing andrepresentation area.

Jorge Luis Childres Flores, - Director of Quality Assurance

Dr. Childres Flores graduated from the National Polytechnic Institute in Mexico City. He previously worked in thepharmaceutical industry as a clinical monitor and products dossier registrations. Currently is the director of quality assuranceand is responsible for maintaining quality standards throughout all clinical trials conducted at IMIC.

Alissia Lomas - Director of Telemarketing

Ms. Lomas has a degree in Marketing from the Universidad Tecnologica de Mexico (UNITEC). She joined IMIC at the beginningof 2002 with long experience in developing marketing plans. Presently she is the responsible of the development andimplementation of patient recruitment strategies for most study protocols. Also, she manages the Central Call Center for IMICwhere all patients interested in participate in study protocols are registered.

Patient Demographics

Mexico City has a population of approximately 25 million people, most under middle age and within one hour of our site or any of our affiliated institutions. From our previous clinical research experience, IMIC has created a patient database with more than 15,000 patients that have been recruited via news paper or physician referrals.

Other Information

All employees are 100% Bilingual, highly trained and fully dedicated to clinical research.

Protocol are reviewed and approved by our local regulatory agency within 45 to 65 days.

Contact Center

If you are interested in contacting this center to discuss placing a clinical trial there, please complete and send the email form below. A representative from the research center will then follow up with you.